RecruitingNCT05701579

Assessment of Anterior Cruciate Ligament (ACL) Degeneratio Mucosa Treatment


Sponsor

Artromedical Konrad Malinowski Clinic

Enrollment

10 participants

Start Date

Jul 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Anterior Cruciate Ligament (ACL) Degeneratio Mucosa is a condition resulting from mucoid degeneration of ACL. Exact etiology is unknown, however ACL Degeneratio Mucosa impairs everyday functioning. In the literature there were some reports of treatment by ACL excision and subsequent reconstruction, however such treatment brings risk of deteriorated function. In this study the investigator will evaluate the technique of ACL "decompression" by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.


Eligibility

Inclusion Criteria2

  • patients with ACL degeneratio mucosa decided to undergo a surgical treatment
  • range of motion impairment caused by mucoid or cystic changes in ACL confirmed by MRI

Exclusion Criteria3

  • non-adherence to the study protocol
  • active knee inflammation
  • range of motion impairment due to other extra- and intra-articular reasons

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREACL "decompression"

The technique of ACL "decompression" by the means of longitudinal incisions and evacuation of extrafibrous mucoid tissue.


Locations(1)

Artromedical Orthopaedic Clinic

Bełchatów, Łódź Voivodeship, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05701579


Related Trials